Spero Therapeutics appoints William Ho to board of directors

SPRO•2026-11-10

Spero Therapeutics appointed William Ho to its board and Development Committee, effective November 10, 2026. Ho replaces Patrick Vink, who is stepping down after 11 years on the board.

1. Board appointment

Spero Therapeutics appointed William Ho to its board and Development Committee, effective November 10, 2026. Ho replaces Patrick Vink, who is stepping down after an 11-year tenure.

2. Ho’s experience

Ho served as RAPT Therapeutics’ chief medical officer from 2015 to December 2025 and has more than 20 years of clinical development experience.

Spero Therapeutics appoints William Ho to board of directors

1. Board appointment

2. Ho’s experience

Related News

Virginia National Bankshares declares 8% stock dividend

Ondas receives order to develop and produce low-cost tactical attack drones

CBRE CEO Bob Sulentic participates in J.P. Morgan Ultimate Services Investor Conference

Supernus CEO to participate in Jefferies Global Healthcare Conference fireside chat

Leonardo DRS wins three-year NAVAIR contract for aircraft protection systems